1.The therapeutic effect of emergency surgery in the treatment of severe valvular heart disease and its influence on heart function
Jiayu HAN ; Siquan ZHANG ; Kexing ZHOU
Chinese Journal of Primary Medicine and Pharmacy 2017;24(20):3073-3075
Objective To analyze the therapeutic effect of emergency surgery in the treatment of severe valvular heart disease and its influence on heart function.Methods 87 cases with severe valvular heart disease were selected,and they were given emergency surgical treatment.Before and after treatment,the cardiac function index[end -diastolic volume (EDV),end-systolic volume (ESV),left ventricular end systolic volume index (LVESVI),left ventricular end-diastolic volume index (LVEDVI),left ventricular ejection fraction (LVEF)],postoperative complications and survival rate were compared.Results After treatment,the EDV [(125.78 ± 31.67) mL],ESV [(71.30 ± 16.58) mL] and LVESVI [(50.39 ± 13.30) mL/m2],LVEDVI [(88.74 ± 13.51) mL/m2],LVEF [(51.48 ± 12.73) %] were better than those before treatment [(116.48 ± 28.94) mL,(63.26 ± 15.47) mL,(33.27 ± 8.54) mL/m2,(64.47 ± 12.69)mL/m2,(47.53 ± 11.20)%],the differences were statistically significant (t =2.022,2.022,3.307,12.213,2.173,all P < 0.05).The incidence rate of complications was 24.14% (21/87),included arrhythmia in 4 cases,low cardiac output syndrome in 8 cases,acute renal failure in 9 cases.Postoperative 1 year,2 years,the survival rates were 91.95% (80/87),85.06% (74/87),respectively.Conclusion Emergency surgical treatment for severe valvular heart disease can effectively improve cardiac function index,improve the survival rate.
2.To Strengthen Teaching Quality of Otorhinolaryngological Advanced Students
Ping LV ; Ji WU ; Siquan TANG ; Tianming ZHOU ; Hongying PU ; Yi WANG
Chinese Journal of Medical Education Research 2006;0(07):-
The teaching for medical advanced students is a routine and important task in teaching hospital.To increase the teaching quality,we should emphasize professional theory learning,increase clinical skill training,strengthen medical records writing training and enhance emotional exchange.
3.The Clinical Observation on the Influence of Guo's MaQian Decoction on Joint Flexion and Extension of Elbow and Knee Joints of Moderate Skeletal Fluorosis
Huiming WANG ; Wei ZHOU ; Peihua GUO ; Zhicheng SANG ; Zhaojie ZHANG ; Ling ZHAO ; Guannan WU ; Sixiu GUO ; Siquan GUO
International Journal of Traditional Chinese Medicine 2009;31(3):212-214
Objective To observe the degree of joint flexion and extension of elbow and knee joints of moderate skeletal fluorosis patients before and after treatment and to assess the effects of Gun's MaQian decoction in treating moderate skeletal fluorosis. Methods 54 moderate skeletal fluorosis patients were randomly recruited into a treatment group and a control group. The treatment group was treated with Gun's MaQian decoction initially, and changed to be treated with GuKangNing capsule after 8 weeks' treatment. The control group was treated with placebo at first, and also changed to be treated with GuKangNing capsule after 8 weeks. Results Joint flexion and extension of elbow was improved greatly in both groups after the treatment, while the treatment group showing better effects than the control group (P<0.05). The improvement of joint flexion and extension of knee had not showed a statistical significance after the treatment. A 24 weeks follow-up to the joint flexion and extension of both elbow and knee revealed obvious improvement and the difference between the two groups were significance (P<0.05). Conclusion Gun's MaQian decoction can improve the flexion and extension of elbow and knee in moderate skeletal fluorosis patients.
4.Blood glucose variability, NIHSS score, APACHE II score, and prognosis in patients with acute and severe cerebrovascular disease
Zhilei QIU ; Siquan ZHANG ; Kexing ZHOU
Chinese Journal of Primary Medicine and Pharmacy 2021;28(7):992-996
Objective:To investigate blood glucose variability, National Institutes of Health Stroke Scale (NIHSS) score, Acute Physiology and Chronic Health Evaluation II (APACHE II) score and prognosis in patients with acute and severe cerebrovascular disease, providing a reference for clinical treatment of this disease.Methods:The clinical data of 76 patients with acute and severe cerebrovascular disease who received treatment in Xixi Hospital of Hangzhou between January 2014 and December 2019 were retrospectively analyzed. These patients were divided into a survival group ( n = 51) and a death group ( n = 25) according to the prognosis 28 days after admission. Baseline data, baseline NIHSS score, APACHE II score, standard deviation of blood glucose, mean blood glucose, mean amplitude of glycemic excursions, and blood glucose variability rate were compared between the survival and death groups. The effects of these parameters on the prognosis of acute and severe cerebrovascular disease were analyzed. Results:There were no significant differences in gender, age, history of diabetes, type of disease, and length of hospital stay between the two groups ( χ2 = 1.674, t = 1.048, χ2 = 3.833, 0.263, t = 0.832, all P > 0.05). The proportion of patients with a history of hypertension in the death group was significantly higher than that in the survival group [15.69% (8/51) vs. 52.00% (13/25), χ2 = 11.063, P < 0.05]. There was no significant difference in mean blood glucose between the two groups ( t = 0.118, P > 0.05). The baseline NIHSS score, APACHE II score, standard deviation of blood glucose, mean amplitude of glycemic excursions and blood glucose variability rate in the death group were (24.41 ± 4.14) points, (25.00 ± 6.97) points, (2.72 ± 0.91) mmol/L, (6.27 ± 2.01) mmol/L, (34.83 ± 5.61) %,which were significantly higher than those in the survival group [(17.22 ± 3.63) points, (19.21 ± 5.36) points, (1.69 ± 0.70) mmol/L, (3.72 ± 1.68) mmol/L, (19.54 ± 3.22) %, t = 7.744, 3.999, 5.448, 5.823, 15.095, all P < 0.05]. The proportion of patients with blood glucose variability rate < 20% in the death group was significantly lower than that in the survival group [16.00% (4/25) vs. 74.51% (38/51), χ2= 23.230, P < 0.05]. The proportion of patients with blood glucose variability rate > 30% in the death group was significantly higher than that in the survival group [60.00% (15/25) vs. 13.73% (7/51), χ2 = 17.466, P < 0.05). Logistic regression analysis revealed that baseline NIHSS score, APACHE II score, standard deviation of blood glucose, mean amplitude of glycemic excursions, and blood glucose variability rate were the independent risk factors of death of cerebrovascular disease patients (all P < 0.05). Conclusion:In patients with acute and severe cerebrovascular disease, an obvious blood glucose fluctuation, high baseline NIHSS score, and high APACHE II score help to assess the prognosis of acute and severe cerebrovascular disease and determine the risk of death.
5.Experiences of nasal reconstruction with forehead flap: reports of 13 cases.
Siquan TANG ; Jun FENG ; Jinsong WEN ; Ping LÜ ; Yanli HUANG ; Hongying PU ; Jianhui ZHANG ; Bei LI ; Tianming ZHOU ; Longyue LIU ; Bifeng WANG ; Zhaohua CHE
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2007;21(5):202-203
OBJECTIVE:
To present the experience of nasal reconstruction with forehead flap.
METHOD:
nasal reconstruction with forehead flap were applied in eight nasal carcinoma cases after operation and 5 nasal trauma cases with defects.
RESULT:
These forehead flaps were alive in all patients, all incision healed in I stage, no post operative complications were found. The shapes of nose were satisfactory, there were no recurrence of tumor during 1 to 17 year follow up.
CONCLUSION
The method can be clinically applied for its simple procedure, reliable flap's blood supply, high survival rate and satisfied result.
Adolescent
;
Adult
;
Aged
;
Female
;
Forehead
;
surgery
;
Humans
;
Male
;
Middle Aged
;
Nose
;
injuries
;
surgery
;
Rhinoplasty
;
methods
;
Skin Transplantation
;
Surgical Flaps
;
Young Adult
7.Identification of novel candidate genes in East Asian COPD patients by the functional summary-based imputation and the unified test for molecular signatures: a transcriptome-wide association study.
Ye TIAN ; Shufang SHAN ; Qixue BAO ; Siquan ZHOU ; Xia JIANG ; Mengqiao WANG ; Shu YIN ; Jingyuan XIONG ; Guo CHENG
Chinese Medical Journal 2023;136(13):1612-1614